MedAlliance (Drug Delivery) Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
68
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
- Investments
-
1
MedAlliance (Drug Delivery) General Information
Description
Developer of innovative drug-eluting balloons (DEBs) based in Nyon, Switzerland. The company develops a sirolimus micro-reservoir drug-coated balloon to treat patients suffering from peripheral artery disease (PAD), coronary artery disease (CAD), arteriovenous fistulas (AVF) and grafts (AVG) for end-stage renal disease, enabling patients to recover from life-threatening diseases quickly.
Contact Information
Website
www.medalliance.comCorporate Office
- Rue De Rive 5
- 1260 Nyon
- Switzerland
Corporate Office
- Rue De Rive 5
- 1260 Nyon
- Switzerland
MedAlliance (Drug Delivery) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MedAlliance (Drug Delivery) Comparisons
Industry
Financing
Details
MedAlliance (Drug Delivery) Competitors (1)
One of MedAlliance (Drug Delivery)’s competitors is Concept Medical, a Private Equity-Backed company based in Tampa, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Concept Medical | Private Equity-Backed | Tampa, FL |
MedAlliance (Drug Delivery) Patents
MedAlliance (Drug Delivery) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023232814-A1 | Sirolimus microspheres and method of making sirolimus microspheres | Pending | 07-Mar-2022 | ||
| EP-4489753-A1 | Sirolimus microspheres and method of making sirolimus microspheres | Active | 07-Mar-2022 | ||
| EP-4489753-B1 | Sirolimus microspheres and method of making sirolimus microspheres | Active | 07-Mar-2022 | ||
| EP-4489753-C0 | Sirolimus microspheres and method of making sirolimus microspheres | Active | 07-Mar-2022 | ||
| US-20230277510-A1 | Sirolimus microspheres and method of making sirolimus microspheres | Pending | 07-Mar-2022 | A61K9/19 |
MedAlliance (Drug Delivery) Signals
MedAlliance (Drug Delivery) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MedAlliance (Drug Delivery) Investments (1)
MedAlliance (Drug Delivery)’s most recent deal was a Buyout/LBO with MDK Medical. The deal was made on 02-Feb-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MDK Medical | 02-Feb-2022 | Buyout/LBO | Laboratory Services (Healthcare) |
MedAlliance (Drug Delivery) FAQs
-
When was MedAlliance (Drug Delivery) founded?
MedAlliance (Drug Delivery) was founded in 2008.
-
Where is MedAlliance (Drug Delivery) headquartered?
MedAlliance (Drug Delivery) is headquartered in Nyon, Switzerland.
-
What is the size of MedAlliance (Drug Delivery)?
MedAlliance (Drug Delivery) has 68 total employees.
-
What industry is MedAlliance (Drug Delivery) in?
MedAlliance (Drug Delivery)’s primary industry is Drug Delivery.
-
Is MedAlliance (Drug Delivery) a private or public company?
MedAlliance (Drug Delivery) is a Private company.
-
What is the current valuation of MedAlliance (Drug Delivery)?
The current valuation of MedAlliance (Drug Delivery) is .
-
What is MedAlliance (Drug Delivery)’s current revenue?
The current revenue for MedAlliance (Drug Delivery) is .
-
How much funding has MedAlliance (Drug Delivery) raised over time?
MedAlliance (Drug Delivery) has raised $72M.
-
Who are MedAlliance (Drug Delivery)’s investors?
CITIC Capital, Shenzhen Salubris Pharmaceuticals, and Welsh, Carson, Anderson & Stowe have invested in MedAlliance (Drug Delivery).
-
Who are MedAlliance (Drug Delivery)’s competitors?
Concept Medical is a competitor of MedAlliance (Drug Delivery).
-
When was MedAlliance (Drug Delivery) acquired?
MedAlliance (Drug Delivery) was acquired on 01-Jan-2023.
-
Who acquired MedAlliance (Drug Delivery)?
MedAlliance (Drug Delivery) was acquired by Cordis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process